AbbVie Inc. (NYSE:ABBV) | Bristol-Myers Vs. Abbvie In Potential Humira Rivalry

[at Seeking Alpha] – Bristol-Myers Squibb ( BMY )’s new experimental drug for rheumatoid arthritis (RA) caused excitement at a conference in October. It appears that the drug clazakizumab is as effective as . . . → Read More: AbbVie Inc. (NYSE:ABBV) | Bristol-Myers Vs. Abbvie In Potential Humira Rivalry Similar posts: Bristol-Myers Squibb Company (NYSE:BMY) – Bristol-Myers Squibb Gains 6% on Promising Cancer Treatment, Upgrade [at Barrons.com] – Shares of Bristol-Myers Squibb (BMY) have... Johnson & Johnson (NYSE:JNJ) – U.S. guidelines expand potential uses of J&J TB drug [Reuters] – New federal guidelines expand the range of... Market Update on Bristol-Myers Squibb Company (NYSE:BMY) – June 2014 Options Now Available For Bristol-Myers Squibb (BMY) [at Forbes] – Investors in Bristol-Myers Squibb Co. (NYSE:...